NCT00276484
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)
See it on ClinicalTrials.gov ↗579 people
39.4%
60.6%
228 womenmiddle line = equal numbers351 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2008-03
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years – 79 Years
- Average age
- mean 61.3 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 81% · Black / African American 10.5% · More than one race 6.4% · Asian 2.1%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating women or intending to become pregnant”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating women or intending to become pregnant”
Study titles and rules are shown in their original English.